SVP, GEN COUNSEL AND SECRETARY · Theravance Biopharma, Inc. · Ordinary Shares
Side
D
Value
—
Shares
23.4K
Price
—
Executed
Sep 23, 2026
Disclosed
Sep 24, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 23 executedSep 24, 2026 disclosed
TBPH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Grimaud Brett A. filed this Form 4 reporting a disposition to issuer of TBPH on Sep 23, 2026. It became public on Sep 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, GEN COUNSEL AND SECRETARY
Grimaud Brett A.cik:0001966698
Issuer
Theravance Biopharma, Inc.cik:0001583107
Revision history · 0
No field has changed since this record was first ingested.
